Day: May 14, 2025

LIMASSOL, Cyprus, May 14, 2025 (GLOBE NEWSWIRE) — Castor Maritime Inc. (NASDAQ: CTRM) (“Castor” or the “Company”), a diversified global shipping and energy company, today announced its results for the three months and year ended December 31, 2024. Highlights of the Year Ended December 31, 2024:Total vessel revenues from continuing operations: $65.1 million for the year ended December 31, 2024, as compared to $97.5 million for the year ended December 31, 2023, or a 33.2% decrease; Net income from continuing operations: $15.3 million for the year ended December 31, 2024, as compared to net income of $21.3 million for the year ended December 31, 2023, or a 28.2% decrease; Net income of $15.3 million for the year ended December 31, 2024, as compared to $38.6 million for the year ended December 31, 2023, or a 60.4% decrease; Earnings...

Updates Progress of Tariff Mitigation Strategy and Announces Cost Optimization Plan Designed to Reduce Annual Spending by $5 – $6 Million SUMMIT, N.J., May 14, 2025 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”), a consumer products company, today announced financial results for the first quarter ended March 31, 2025 (“Q1 2025”). The Company also provided an update on a series of initiatives that are underway to mitigate the impact of tariffs on the Company’s performance, including the commencement of a cost optimization plan designed to produce annual savings of approximately $5 – $6 million. “While tariffs did not have a direct impact on our first quarter results, the uncertainty in the broader macroeconomic environment led to some softness in consumer demand,” said Arturo Rodriguez,...

IRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) — Shimmick Corp. (NASDAQ: SHIM), a leading infrastructure solutions provider in water, climate resilience, energy transition and sustainable transportation, today announced financial results for the first quarter ended April 4, 2025. HighlightsReported revenue of $122 million, which includes $93 million of Shimmick Projects revenue Reported gross margin of $5 million, as compared to gross margin of $(16) million during the first quarter of 2024 Reported selling, general and administrative expenses of $14 million, down 11% from the first quarter of 2024 as a result of the continued implementation of the transformation plan Recognized a net loss of $10 million and Adjusted EBITDA of $(3) million, largely attributable to Legacy Projects Reported liquidity of $71 million as of April 4,...

CULVER CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) —  Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, today announced financial results for its first quarter ended March 31, 2025. First Quarter 2025 and Recent Operational Highlights ARK Franchise Updates:ARK: Survival Evolved (“ASE”):Units sold were approximately 690,775 for the first quarter 2025 Revealed teaser trailer for ARK: Aquatica, a new in-house developed downloadable content (“DLC”) expansion map for ASEARK: Survival Ascended (“ASA”):Units sold were approximately 751,960 for the first quarter 2025 Launched the Astraeos Map as an Official Partner DLC for ASA Revealed the official trailer for ARK: Lost Colony, the next DLC for ASA produced by Studio WildcardARK:...

Advancing IKT-001 into a Late-Stage Clinical Trial Program in Pulmonary Arterial Hypertension BOSTON and ATLANTA, May 14, 2025 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial hypertension (“PAH”), today reported financial results for the quarter ended March 31, 2025 and highlighted recent developments. “During our first quarter of 2025, we continued to build out our senior leadership team and key infrastructure areas to position the Company to advance IKT-001 toward a late-stage clinical trial in PAH,” said Mark Iwicki, Chief Executive Officer of Inhibikase. “With our core team now in place, and with ongoing refining of our study protocol with key opinion leaders,...

Record highs across key financial and operational metrics.TPV milestone of US$8 billion, +53% YoY and +5% QoQ. In constant currency, TPV increased +72% YoY.Revenue and gross profit record highs of US$217 million and US$85 million. Continued geographic diversification.Adjusted EBITDA of US$58 million, with Adjusted EBITDA/Gross Profit at 68%, demonstrating our ability to scale efficiently.Strong cash flow, with free cash flow to net income conversion at 85%, reinforcing cash generating financial model. MONTEVIDEO, Uruguay, May 14, 2025 (GLOBE NEWSWIRE) — DLocal Limited (“dLocal”, “we”, “us”, and “our”) (NASDAQ:DLO), a technology – first payments platform, today announced its financial results for the first quarter ended March 31, 2025. dLocal’s management team will host a conference call and audio webcast on May 14, 2025 at...

– Continue to conduct analytical studies to prepare for a potential Biosimilar Biological Product Development (“BPD”) Type 2a meeting with the FDA in the second half of 2025 – – Pursuing a 351(k) regulatory pathway for ABP-450, which offers potential access to the U.S. market under a single approval for all of BOTOX’s currently approved and future therapeutic indications – – Appointed Rob Bancroft as the Company’s President and Chief Executive Officer; Mr. Bancroft also joined AEON’s Board of Directors – IRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, announced its financial results for the first quarter ended March 31, 2025,...